Armistice Capital, LLC: 13F holdings, Q2 2026
Hedge fund · SEC EDGAR filings (CIK 1601086) · Explore on the interactive board
Armistice Capital, LLC disclosed 323 US equity positions worth $3.6bn in its Q2 2026 13F filing (holdings as of June 30, 2026, filed August 14, 2026). Its largest position is MDGL at 4.3% of the reported book, followed by SUPN, CYTK. The top ten holdings are 27.4% of the book, and the portfolio behaves like about 71 equal-weight positions. Versus the prior filing it opened 169 new positions, added to 70, reduced 64 and exited 25. Note: this manager's most recent filing is 3934 quarters behind the newest quarter on file, so these figures are history rather than current positioning.
What does Armistice Capital, LLC own? Top holdings as of June 30, 2026
Change is measured in shares against the previous filing (Q1 2026), so price moves do not read as decisions. This quarter: 169 new, 70 added, 64 reduced, 25 exited.
| # | Stock | Sector | Weight | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|---|
| 1 | MDGL MADRIGAL PHARMACEUTICALS INC | Healthcare | 4.3% | $154.6m | 288,000 | 9% | added |
| 2 | SUPN SUPERNUS PHARMACEUTICALS | Healthcare | 3.4% | $123.1m | 2,646,201 | 40% | added |
| 3 | CYTK CYTOKINETICS INC | Healthcare | 2.8% | $102.3m | 1,201,342 | 57% | added |
| 4 | INCY INCYTE CORP | Healthcare | 2.8% | $102.0m | 900,005 | 37% | added |
| 5 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 2.5% | $90.3m | 535,838 | -26% | reduced |
| 6 | TVTX TRAVERE THERAPEUTICS INC | Healthcare | 2.5% | $89.3m | 1,572,539 | -68% | reduced |
| 7 | AGIO AGIOS PHARMACEUTICALS INC | Healthcare | 2.5% | $89.1m | 2,400,000 | -12% | reduced |
| 8 | PTCT PTC THERAPEUTICS INC | Healthcare | 2.4% | $87.4m | 1,071,395 | -48% | reduced |
| 9 | UNH UNITEDHEALTH GROUP INC | Healthcare | 2.1% | $76.1m | 183,000 | 24% | added |
| 10 | FRPT FRESHPET INC | Consumer Defensive | 2.1% | $74.5m | 1,260,702 | 15% | added |
| 11 | DYN DYNE THERAPEUTICS INC | Healthcare | 1.9% | $68.6m | 3,087,226 | -3% | reduced |
| 12 | AMZN AMAZON COM INC | Consumer Cyclical | 1.9% | $67.8m | 284,562 | 9% | added |
| 13 | IMVT IMMUNOVANT INC | Healthcare | 1.9% | $66.9m | 1,736,000 | -51% | reduced |
| 14 | RIGL RIGEL PHARMACEUTICALS INC | 1.8% | $65.4m | 1,672,000 | 31% | added | |
| 15 | TMO THERMO FISHER SCIENTIFIC INC | Healthcare | 1.7% | $61.4m | 122,480 | 34% | added |
| 16 | IRWD IRONWOOD PHARMACEUTICALS INC | Healthcare | 1.6% | $58.7m | 13,932,000 | -7% | reduced |
| 17 | HRMY HARMONY BIOSCIENCES HLDGS IN | Healthcare | 1.6% | $56.9m | 1,564,000 | -4% | reduced |
| 18 | REGN REGENERON PHARMACEUTICALS | Healthcare | 1.5% | $56.0m | 89,809 | 149% | added |
| 19 | NKTR NEKTAR THERAPEUTICS | Healthcare | 1.4% | $50.5m | 724,000 | 25% | added |
| 20 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 1.3% | $46.8m | 1,736,000 | 48% | added |
| 21 | SNY SANOFI SA | Healthcare | 1.3% | $45.4m | 1,064,000 | 255% | added |
| 22 | IMCR IMMUNOCORE HLDGS PLC | Healthcare | 1.3% | $45.3m | 1,428,000 | 20% | added |
| 23 | GOOGL ALPHABET INC | Communication Services | 1.3% | $45.2m | 126,494 | 7% | added |
| 24 | SLDB SOLID BIOSCIENCES INC | Healthcare | 1.2% | $42.7m | 4,278,000 | 34% | added |
| 25 | MDB MONGODB INC | Technology | 1.2% | $42.0m | 125,172 | 17% | added |
| 26 | KURA KURA ONCOLOGY INC | Healthcare | 1.1% | $40.3m | 3,678,000 | -2% | reduced |
| 27 | XRAY DENTSPLY SIRONA INC | Healthcare | 1.1% | $39.0m | 3,672,000 | 22% | added |
| 28 | UBER UBER TECHNOLOGIES INC | Technology | 1.0% | $35.9m | 497,908 | -4% | reduced |
| 29 | AXGN AXOGEN INC | Healthcare | 1.0% | $35.8m | 775,000 | -17% | reduced |
| 30 | IRON DISC MEDICINE INC | Healthcare | 0.9% | $33.6m | 460,000 | -14% | reduced |
| 31 | GTLB GITLAB INC | Technology | 0.9% | $32.8m | 1,074,141 | 4% | added |
| 32 | FIVN FIVE9 INC | Technology | 0.9% | $32.7m | 1,536,000 | -4% | reduced |
| 33 | HUBS HUBSPOT INC | Technology | 0.9% | $32.5m | 178,047 | 38% | added |
| 34 | ALGN ALIGN TECHNOLOGY INC | Healthcare | 0.8% | $30.4m | 180,286 | 14% | added |
| 35 | MSFT MICROSOFT CORP | Technology | 0.8% | $30.1m | 80,581 | 65% | added |
| 36 | OFIX ORTHOFIX MED INC | Healthcare | 0.8% | $29.8m | 3,264,000 | 21% | added |
| 37 | HUM HUMANA INC | Healthcare | 0.8% | $28.8m | 72,527 | -49% | reduced |
| 38 | ANGO ANGIODYNAMICS INC | Healthcare | 0.8% | $28.6m | 2,198,000 | 18% | added |
| 39 | WAT WATERS CORP | Healthcare | 0.8% | $28.1m | 75,004 | – | new |
| 40 | VSTM VERASTEM INC | Healthcare | 0.7% | $26.8m | 7,024,000 | 53% | added |
| 41 | FDMT 4D MOLECULAR THERAPEUTICS IN | Healthcare | 0.7% | $26.6m | 2,000,000 | 0% | held |
| 42 | NTLA INTELLIA THERAPEUTICS INC | Healthcare | 0.7% | $25.4m | 1,500,000 | 346% | added |
| 43 | WYNN WYNN RESORTS LTD | Consumer Cyclical | 0.7% | $25.3m | 261,065 | 50% | added |
| 44 | TMCI TREACE MED CONCEPTS INC | Healthcare | 0.7% | $25.3m | 6,364,000 | 0% | held |
| 45 | AUTL AUTOLUS THERAPEUTICS LTD | Healthcare | 0.7% | $24.0m | 15,000,000 | -5% | reduced |
| 46 | ARVN ARVINAS INC | Healthcare | 0.6% | $23.2m | 2,796,000 | 41% | added |
| 47 | MGNX MACROGENICS INC | Healthcare | 0.6% | $23.1m | 5,006,752 | -17% | reduced |
| 48 | ANRO ALTO NEUROSCIENCE INC | Healthcare | 0.6% | $22.8m | 864,000 | -5% | reduced |
| 49 | TOST TOAST INC | Technology | 0.6% | $22.6m | 810,830 | 40% | added |
| 50 | PATH UIPATH INC | Technology | 0.6% | $21.7m | 2,000,000 | 56% | added |
What did Armistice Capital, LLC sell? Positions exited since the previous filing
| Stock | Prior weight | Prior value |
|---|---|---|
| 8HH AVANOS MED INC | 10.7% | $28.0m |
| MDLN MEDLINE INC | 9.6% | $25.1m |
| 4XC1 KALVISTA PHARMACEUTICALS INC | 9.5% | $24.9m |
| ENR ENERGIZER HLDGS INC | 7.5% | $19.7m |
| META META PLATFORMS INC | 7.1% | $18.6m |
| ESPERION THERAPEUTICS INC NE | 4.1% | $10.8m |
| IQV IQVIA HLDGS INC | 4.0% | $10.4m |
| SGMOQ SANGAMO THERAPEUTICS INC | 3.8% | $10.0m |
| GEHC GE HEALTHCARE TECHNOLOGIES I | 3.2% | $8.4m |
| TENX TENAX THERAPEUTICS INC | 2.9% | $7.7m |
| NVST ENVISTA HOLDINGS CORPORATION | 2.6% | $6.7m |
| ICLR ICON PLC | 2.5% | $6.7m |
| DVA DAVITA INC | 2.5% | $6.6m |
| LCTX LINEAGE CELL THERAPEUTICS IN | 1.9% | $5.0m |
| AS AMER SPORTS INC | 1.9% | $4.9m |
| PRTA PROTHENA CORP PLC | 1.6% | $4.3m |
| KEYS KEYSIGHT TECHNOLOGIES INC | 1.6% | $4.2m |
| MTSI MACOM TECH SOLUTIONS HLDGS I | 1.4% | $3.7m |
| MCD MCDONALDS CORP | 1.4% | $3.6m |
| CRBP CORBUS PHARMACEUTICALS HLDGS | 1.3% | $3.4m |
| FIX COMFORT SYS USA INC | 1.2% | $3.2m |
| AMD ADVANCED MICRO DEVICES INC | 1.2% | $3.2m |
| CIEN CIENA CORP | 1.2% | $3.2m |
| ONTO ONTO INNOVATION INC | 1.1% | $2.9m |
| VSXY VICTORIAS SECRET AND CO | 1.0% | $2.6m |
Sector mix
| Sector | Weight |
|---|---|
| Healthcare | 64.6% |
| Technology | 14.7% |
| Consumer Cyclical | 7.7% |
| Communication Services | 4.2% |
| Consumer Defensive | 3.2% |
| Industrials | 1.2% |
Sectors cover positions whose ticker resolved to a sector; the remainder is unclassified, not cash.
Filing history
How concentrated is Armistice Capital, LLC's portfolio?
Across every quarter Armistice Capital, LLC has filed, its median largest position is 4.5% of the book and its median top-ten weight is 29.9%, which WhaleCreep classifies as diversified (the gate is a median largest position of 5%). Of 97.0 completed holding spells, the median lasted 1.0 quarters; 323.0 positions are still open and their final length is unknown.